2361 Modified FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for gemcitabine-resistant or -refractory advanced pancreatic cancer

Autor:	Kyu-Taek Lee, Joung-Soon Jang, Dae-Keun Lim, Nyun Jong Lee, In-Tae Hwang, Ju-Won Kang, Jun-Seong Yoon, Eun Mi Nam, Won Jongwoo, Suyeon Lee, Sung-Hwa Oh, Deukjo Hong, Sujin Bae, Seo-Young Song, Hyung-Jin Lee, Sue-Young Lee, Hyun-Gyu Lee, Kyusoon Kim, Hyun Jung Kim, Han Jo Kim
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty FOLFIRINOX business.industry medicine.disease Second line chemotherapy Gemcitabine Oxaliplatin Irinotecan Refractory Internal medicine Pancreatic cancer medicine business medicine.drug
Zdroj:	European Journal of Cancer. 51:S456
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7550ef09b1418ee4705d2cf490ad8344 https://doi.org/10.1016/s0959-8049(16)31277-1 Zobrazit plný text záznamu Full Text from ScienceDirect